Subscribe to stay informed!
Trevena, a biopharmaceutical company based in Chesterbrook, has entered into a royalty-based financing deal with an affiliate of R-Bridge Healthcare Fund that could…
After the FDA approved its new pain medication, Olinvyk, earlier this month, Chesterbrook-based Trevena has received a $3 million milestone payment from its licensing…
Chesterbrook-based Trevena saw its stock surge by 50 percent after the FDA approved its new pain medicine on Monday, writes John George for the…
Chesterbrook-based Trevena and Wayne-based Aclaris Therapeutics have joined the growing list of drug developers currently working on potential COVID-19 treatments, writes John…
Chesterbrook-based Trevena has refiled its drug application to the Food and Drug Administration for IV oliceridine, an opioid pain relief medicine with fewer side…
Trevena, a rapidly growing biopharmaceutical company, is about to become the newest tenant in Wayne’s Chesterbrook Corporate Center after signing a 10-year lease…
Before we send you to this site, please subscribe to our daily newsletter.